GLP1R and Stroke: A meta-analysis of 48 randomized trials (RCT) indicated that the risk ratio of stroke was 0.85 (95%CI 0.77–0.94) for GLP-1 receptor agonists (GLP1-RA) and 0.82 (0.69–0.98) for thiazolidinediones [5].